Literature DB >> 19855861

The status of nutraceuticals for the treatment of depression.

Steven D Targum1, David Mischoulon.   

Abstract

Entities:  

Year:  2009        PMID: 19855861      PMCID: PMC2766289     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


× No keyword cloud information.
  8 in total

1.  Are nutritional supplements ready for prime time?

Authors:  David Mischoulon; Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2008-09       Impact factor: 4.384

2.  Folate supplementation: is it safe and effective?

Authors:  Frances R Frankenburg
Journal:  J Clin Psychiatry       Date:  2009-05       Impact factor: 4.384

Review 3.  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.

Authors:  Marlene P Freeman; Joseph R Hibbeln; Katherine L Wisner; John M Davis; David Mischoulon; Malcolm Peet; Paul E Keck; Lauren B Marangell; Alexandra J Richardson; James Lake; Andrew L Stoll
Journal:  J Clin Psychiatry       Date:  2006-12       Impact factor: 4.384

Review 4.  Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.

Authors:  David Mischoulon; Maurizio Fava
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045

5.  S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.

Authors:  Jonathan E Alpert; George Papakostas; David Mischoulon; John J Worthington; Timothy Petersen; Yasmin Mahal; Alana Burns; Teodoro Bottiglieri; Andrew A Nierenberg; Maurizio Fava
Journal:  J Clin Psychopharmacol       Date:  2004-12       Impact factor: 3.153

6.  A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.

Authors:  David Mischoulon; George I Papakostas; Christina M Dording; Amy H Farabaugh; Shamsah B Sonawalla; A Monica Agoston; Juliana Smith; Erin C Beaumont; Liat E Dahan; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2009-08-25       Impact factor: 4.384

7.  A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.

Authors:  David Mischoulon; Catherine Best-Popescu; Michael Laposata; Wendelien Merens; Jessica L Murakami; Shirley L Wu; George I Papakostas; Christina M Dording; Shamsah B Sonawalla; Andrew A Nierenberg; Jonathan E Alpert; Maurizio Fava
Journal:  Eur Neuropsychopharmacol       Date:  2008-06-06       Impact factor: 4.600

8.  L-methylfolate: a vitamin for your monoamines.

Authors:  Stephen M Stahl
Journal:  J Clin Psychiatry       Date:  2008-09       Impact factor: 4.384

  8 in total
  1 in total

Review 1.  Emerging Role of Flavonoids as the Treatment of Depression.

Authors:  Arzoo Pannu; Prabodh Chander Sharma; Vijay Kumar Thakur; Ramesh K Goyal
Journal:  Biomolecules       Date:  2021-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.